These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 4038645)

  • 1. Vasoactive intestinal peptide is a physiological mediator of prolactin release in the rat.
    Abe H; Engler D; Molitch ME; Bollinger-Gruber J; Reichlin S
    Endocrinology; 1985 Apr; 116(4):1383-90. PubMed ID: 4038645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolactin gene expression and secretion during pregnancy and lactation in the rat: role of dopamine and vasoactive intestinal peptide.
    Escalada J; Cacicedo L; Ortego J; Melian E; Sánchez-Franco F
    Endocrinology; 1996 Feb; 137(2):631-7. PubMed ID: 8593812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the role for prolactin-releasing peptide in prolactin secretion induced by ether stress and suckling in the rat: comparison with vasoactive intestinal peptide.
    Watanobe H; Schiöth HB; Wikberg JE; Suda T
    Brain Res; 2000 May; 865(1):91-6. PubMed ID: 10814736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The peak phase of the proestrous prolactin surge is blocked by either posterior pituitary lobectomy or antisera to vasoactive intestinal peptide.
    Murai I; Reichlin S; Ben-Jonathan N
    Endocrinology; 1989 Feb; 124(2):1050-5. PubMed ID: 2492217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of passive immunization with antisera to vasoactive intestinal polypeptide and peptide histidine isoleucine amide on 5-hydroxy-L-tryptophan-induced prolactin release in rats.
    Kaji H; Chihara K; Abe H; Kita T; Kashio Y; Okimura Y; Fujita T
    Endocrinology; 1985 Nov; 117(5):1914-9. PubMed ID: 3876209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasoactive intestinal polypeptide antiserum affects rat prolactin mRNA in 40-day but not 110-day diethylstilbestrol-induced prolactinoma tissue.
    Maas DL; Meier DA; Wahle JS; Martinson DR; Hagen TC
    Mol Cell Neurosci; 1994 Apr; 5(2):182-8. PubMed ID: 8032686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxytocin mediates the hypothalamic action of vasoactive intestinal peptide to stimulate prolactin secretion.
    Samson WK; Bianchi R; Mogg RJ; Rivier J; Vale W; Melin P
    Endocrinology; 1989 Feb; 124(2):812-9. PubMed ID: 2912703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does alpha-melanocyte-stimulating hormone from the pars intermedia regulate suckling-induced prolactin release? Supportive evidence from morphological and functional studies.
    Hill JB; Lacy ER; Nagy GM; Görcs TJ; Frawley LS
    Endocrinology; 1993 Dec; 133(6):2991-7. PubMed ID: 8243327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autocrine and/or paracrine action of vasoactive intestinal peptide on thyrotropin-releasing hormone induced prolactin release.
    Balsa JA; Cacicedo L; Lara JI; Lorenzo MJ; Pazos F; Sanchez-Franco F
    Endocrinology; 1996 Jan; 137(1):144-50. PubMed ID: 8536606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suckling-induced changes of vasoactive intestinal peptide concentrations in hypothalamic areas implicated in the control of prolactin release.
    Chiocchio SR; de las Nieves Parisi M; Vitale ML; Tramezzani JH
    Neuroendocrinology; 1991 Jul; 54(1):77-82. PubMed ID: 1922680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for a synergistic effect of somatostatin on vasoactive intestinal polypeptide-induced prolactin release in the rat: comparison with its effect on thyrotropin (TSH)-releasing hormone-stimulated TSH release.
    Michalkiewicz M; Suzuki M; Kato M
    Endocrinology; 1987 Jul; 121(1):371-7. PubMed ID: 2885177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Administration of antisera to vasoactive intestinal polypeptide and peptide histidine isoleucine attenuates ether-induced prolactin secretion in rats.
    Kaji H; Chihara K; Kita T; Kashio Y; Okimura Y; Fujita T
    Neuroendocrinology; 1985 Dec; 41(6):529-31. PubMed ID: 3841194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active immunization against vasoactive intestinal peptide prevents photo-induced prolactin secretion in turkeys.
    el Halawani ME; Pitts GR; Sun S; Silsby JL; Sivanandan V
    Gen Comp Endocrinol; 1996 Oct; 104(1):76-83. PubMed ID: 8921358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypothalamic factors involved in the endogenous stimulatory rhythm regulating prolactin secretion.
    Arey BJ; Freeman ME
    Endocrinology; 1989 Feb; 124(2):878-83. PubMed ID: 2521468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisera to vasoactive intestinal polypeptide inhibit basal prolactin release from dispersed anterior pituitary cells.
    Hagen TC; Arnaout MA; Scherzer WJ; Martinson DR; Garthwaite TL
    Neuroendocrinology; 1986; 43(6):641-5. PubMed ID: 3762862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of prolactin in the REM sleep-promoting activity of systemic vasoactive intestinal peptide (VIP).
    Obál F; Payne L; Kacsoh B; Opp M; Kapás L; Grosvenor CE; Krueger JM
    Brain Res; 1994 May; 645(1-2):143-9. PubMed ID: 8062077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of dopaminergic and peptidergic factors in the control of prolactin release.
    Mogg RJ; Samson WK
    Endocrinology; 1990 Feb; 126(2):728-35. PubMed ID: 2298169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autofeedback regulation of prolactin (PRL) secretion: effect of prolactin before suckling on the subsequent nursing-induced release of PRL in the lactating rat.
    Whitworth NS; Grosvenor CE; Mena F
    Endocrinology; 1981 Apr; 108(4):1279-84. PubMed ID: 7472268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central administration of antiserum to vasoactive intestinal peptide delays and reduces luteinizing hormone and prolactin surges in ovariectomized, estrogen-treated rats.
    van der Beek EM; Swarts HJ; Wiegant VM
    Neuroendocrinology; 1999 Apr; 69(4):227-37. PubMed ID: 10207274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preferential increase in pituitary prolactin versus vasoactive intestinal peptide as a function of estradiol benzoate dose in the ovariectomized rat.
    Carrillo AJ; Doherty PC; Guan XB; Sturtevant JR; Walro DG
    Endocrinology; 1991 Jan; 128(1):131-8. PubMed ID: 1986914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.